Company Filing History:
Years Active: 1978
Title: Koji Miura: Innovator in Pharmaceutical Chemistry
Introduction
Koji Miura is a notable inventor based in Kanazawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address inflammation and pain.
Latest Patents
Miura holds a patent for a novel alkanoic acid, specifically a 2-[4-(3-oxo- or hydroxy-alkyl)phenyl]alkanoic acid and its non-toxic salt. This patent, which is aimed at treating symptoms of inflammation and pain in mammals, including humans, outlines a process for producing these compounds. The pharmaceutical composition derived from this invention is designed to effectively alleviate discomfort associated with various inflammatory conditions.
Career Highlights
Throughout his career, Koji Miura has been associated with Toyama Chemical Co., Ltd., where he has focused on innovative solutions in drug development. His work has led to advancements in the treatment of pain and inflammation, showcasing his commitment to improving healthcare outcomes.
Collaborations
Miura has collaborated with esteemed colleagues such as Kenjun Takeshima and Takuya Kodama. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.
Conclusion
Koji Miura's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the field. His work continues to impact the treatment of inflammation and pain, demonstrating the importance of innovation in healthcare.